Bryan Haugen
Expertise in
9
conditions

Dr. Bryan Haugen

Endocrinology
University Of Colorado Hospital Authority
1635 Aurora Ct, 
Aurora, CO 
Offers Telehealth
Expertise in
9
conditions
University Of Colorado Hospital Authority
1635 Aurora Ct, 
Aurora, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bryan Haugen is an Endocrinologist in Aurora, Colorado. Dr. Haugen is highly rated in 9 conditions, according to our data. His top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 90 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in CO
Hospital Affiliations
Uch-Memorial Health System
University Of Colorado Hospital Authority
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

University of Colorado Hospital Authority
1635 Aurora Ct, Aurora, CO 80045
Call: 720-848-2650
Other Locations
University of Colorado Hospital
1665 Aurora Ct Fl 2, Aurora, CO 80045
Call: 720-848-0000

Additional Areas of Focus

Dr. Haugen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Combination Targeted Therapy With Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers: A Phase II Study
Combination Targeted Therapy With Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers: A Phase II Study
Enrollment Status: Completed
Publish Date: August 29, 2025
Intervention Type: Drug, Other, Biological
Study Drugs: Lenvatinib, Lenvatinib Mesylate, Pembrolizumab
Study Phase: Phase 2
A Phase 2 Study of Efatutazone, an Oral PPAR Agonist, In Combination With Paclitaxel in Patients With Advanced Anaplastic Thyroid Cancer
A Phase 2 Study of Efatutazone, an Oral PPAR Agonist, In Combination With Paclitaxel in Patients With Advanced Anaplastic Thyroid Cancer
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Drug
Study Drugs: Efatutazone, Paclitaxel
Study Phase: Phase 2
Randomized Double-Blind Phase II Study of Radioactive Iodine (RAI) in Combination With Placebo or Selumetinib for the Treatment of RAI-Avid Recurrent/Metastatic Thyroid Cancers
Randomized Double-Blind Phase II Study of Radioactive Iodine (RAI) in Combination With Placebo or Selumetinib for the Treatment of RAI-Avid Recurrent/Metastatic Thyroid Cancers
Enrollment Status: Completed
Publish Date: July 26, 2024
Intervention Type: Other, Drug, Radiation
Study Drugs: Selumetinib, Iodine-131
Study Phase: Phase 2
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Enrollment Status: Completed
Publish Date: October 26, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

89 Total Publications

The Year in Thyroidology 2025-Basic Science, Clinical Science, Surgical Science.
The Year in Thyroidology 2025-Basic Science, Clinical Science, Surgical Science.
Journal: Thyroid : official journal of the American Thyroid Association
Published: December 05, 2025
View All 89 Publications
Similar Doctors
Expertise in
31
conditions
Dr. Margaret Wierman
Endocrinology
Expertise in
31
conditions
Dr. Margaret Wierman
Endocrinology

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.2 miles away)
720-848-2650
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Margaret Wierman is an Endocrinologist in Aurora, Colorado. Dr. Wierman is highly rated in 31 conditions, according to our data. Her top areas of expertise are Adrenocortical Carcinoma, Pituitary Tumor, Adrenal Cancer, Hypothalamic Tumor, and Hormone Replacement Therapy (HRT).

Expertise in
13
conditions
Dr. Lauren Fishbein
Endocrinology
Expertise in
13
conditions
Dr. Lauren Fishbein
Endocrinology

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.2 miles away)
720-848-2650
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lauren Fishbein is an Endocrinologist in Aurora, Colorado. Dr. Fishbein is highly rated in 13 conditions, according to our data. Her top areas of expertise are Pheochromocytoma, Multiple Endocrine Neoplasia Type 2, Neuroendocrine Tumor, and Adrenal Cancer.

Expertise in
6
conditions
Dr. Satish Garg
Endocrinology
Expertise in
6
conditions
Dr. Satish Garg
Endocrinology

Laboratory Corporation Of America

1775 Aurora Ct, 
Aurora, CO 
 (0.1 miles away)
303-724-1923
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Satish Garg is an Endocrinologist in Aurora, Colorado. Dr. Garg is highly rated in 6 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), and Diabetic Ketoacidosis.

VIEW MORE Endocrinologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Haugen's expertise for a condition
ConditionClose
  • Elite
  • Anaplastic Thyroid Cancer
    Dr. Haugen is
    Elite
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Follicular Thyroid Cancer
    Dr. Haugen is
    Elite
    . Learn about Follicular Thyroid Cancer.
    See more Follicular Thyroid Cancer experts
  • Thyroid Cancer
    Dr. Haugen is
    Elite
    . Learn about Thyroid Cancer.
    See more Thyroid Cancer experts
  • Distinguished
  • Medullary Thyroid Carcinoma
    Dr. Haugen is
    Distinguished
    . Learn about Medullary Thyroid Carcinoma.
    See more Medullary Thyroid Carcinoma experts
  • Multiple Endocrine Neoplasia Type 2
    Dr. Haugen is
    Distinguished
    . Learn about Multiple Endocrine Neoplasia Type 2.
    See more Multiple Endocrine Neoplasia Type 2 experts
  • Papillary Thyroid Cancer
    Dr. Haugen is
    Distinguished
    . Learn about Papillary Thyroid Cancer.
    See more Papillary Thyroid Cancer experts
  • Thyroid Nodule
    Dr. Haugen is
    Distinguished
    . Learn about Thyroid Nodule.
    See more Thyroid Nodule experts
  • Advanced
  • Multiple Endocrine Neoplasia
    Dr. Haugen is
    Advanced
    . Learn about Multiple Endocrine Neoplasia.
    See more Multiple Endocrine Neoplasia experts
  • Thyroidectomy
    Dr. Haugen is
    Advanced
    . Learn about Thyroidectomy.
    See more Thyroidectomy experts
  • Experienced
  • Cowden Syndrome
    Dr. Haugen is
    Experienced
    . Learn about Cowden Syndrome.
    See more Cowden Syndrome experts
  • Graves Disease
    Dr. Haugen is
    Experienced
    . Learn about Graves Disease.
    See more Graves Disease experts
  • Hormone Replacement Therapy (HRT)
    Dr. Haugen is
    Experienced
    . Learn about Hormone Replacement Therapy (HRT).
    See more Hormone Replacement Therapy (HRT) experts
  • Hyperparathyroidism
    Dr. Haugen is
    Experienced
    . Learn about Hyperparathyroidism.
    See more Hyperparathyroidism experts
  • Hypothyroidism
    Dr. Haugen is
    Experienced
    . Learn about Hypothyroidism.
    See more Hypothyroidism experts
  • Multiple Endocrine Neoplasia Type 1
    Dr. Haugen is
    Experienced
    . Learn about Multiple Endocrine Neoplasia Type 1.
    See more Multiple Endocrine Neoplasia Type 1 experts
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Endocrinologists Aurora, CO
  3. Dr. Bryan Haugen
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.